ZEB2 and breast carcinoma: Data illustrating that high levels of ZEB2 are expressed in migratory breast cancer cell lines (MDA-MB-231 and MDA-MB-435S1) but not in breast cancer cells with a more epithelial/less migratory phenotype (MCF7/AZ) [44] supports our finding that ZEB2 repression hampers the cellular migration.